Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview

Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview

Glioblastoma is the most common malignant primary brain tumor in adults. Thalidomide is a vascular endothelial growth factor inhibitor that demonstrates antiangiogenic activity, and may provide additive or synergistic anti-tumor effects when co-administered with other antiangiogenic medications. Thi...

Full description

Bibliographic Details
Main Authors: Ahmed Ismail Eatmann, Esraa Hamouda, Heba Hamouda, Hossam Khaled Farouk, Afnan W. M. Jobran, Abdallah A. Omar, Alyaa Khaled Madeeh, Nada Mostafa Al-dardery, Salma Elnoamany, Eman Gamal Abd-Elnasser, Abdullah Muhammed Koraiem, Alhassan Ali Ahmed, Mohamed Abouzid, Marta Karaźniewicz-Łada
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Metabolites
Subjects:
glioblastoma
thalidomide
antineoplastic agents
angiogenesis
chemotherapy
VEGF
Online Access:https://www.mdpi.com/2218-1989/13/4/543

Internet

https://www.mdpi.com/2218-1989/13/4/543

Similar Items